Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Graft-vs.-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00268957
What this trial is testing

Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis

Who this might be right for
Kidney DiseasesChronic Renal InsufficiencyEnd-Stage Renal Disease
Genzyme, a Sanofi Company 217
Not applicableActive Not RecruitingNCT06950060
What this trial is testing

AMPLIFI: Adaptive Modulation of Plasticity Through Lactate and Fitness Interventions

Who this might be right for
Stroke, ChronicAgingCognitive Decline+2 more
University of Alabama at Birmingham 48
Not applicableStudy completedNCT02864589
What this trial is testing

Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder

Who this might be right for
Tourette's DisorderPersistent (Chronic) Motor or Vocal Tic Disorder
Karolinska Institutet 23
Early research (Phase 1)Ended earlyNCT02231710
What this trial is testing

Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases

Who this might be right for
Primary Immune Deficiency DisordersHemophagocytic LymphohistiocytosisInherited Bone Marrow Failure Syndrome+2 more
Bellicum Pharmaceuticals 1
Early research (Phase 1)Active Not RecruitingNCT01937468
What this trial is testing

Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Who this might be right for
Chronic Graft Versus Host DiseaseChronic GVHDComplications of Organ Transplant Stem Cells
Dana-Farber Cancer Institute 25
Early research (Phase 1)Study completedNCT03207958
What this trial is testing

Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Vs Host DiseaseGraft-versus-host-disease
Washington University School of Medicine 10
Large-scale testing (Phase 3)Study completedNCT02321397
What this trial is testing

To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain

Who this might be right for
Malignant PainNon-malignant Pain
Mundipharma Research GmbH & Co KG 155
Testing effectiveness (Phase 2)Study completedNCT00513656
What this trial is testing

A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain

Who this might be right for
CancerPainConstipation
Mundipharma Research GmbH & Co KG 230
Not applicableStudy completedNCT01378728
What this trial is testing

Clinical Validation of a 'Hand-held' Fluorescence Digital Imaging Device for Wound Care Applications

Who this might be right for
Wounds
University Health Network, Toronto 75
Large-scale testing (Phase 3)Study completedNCT01699412
What this trial is testing

Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease

Who this might be right for
Graft vs Host DiseaseOral Manifestations
Grupo de Estudos Multicentricos em Onco-Hematologia 28
Early research (Phase 1)Looking for participantsNCT06462365
What this trial is testing

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Who this might be right for
Hematologic MalignancyGvHDGVHD,Acute+8 more
Tr1X, Inc. 36
Post-approval studies (Phase 4)Active Not RecruitingNCT02386800
What this trial is testing

CINC424A2X01B Rollover Protocol

Who this might be right for
Primary MyelofibrosisPolycythemia VeraGraft Versus Host Disease+2 more
Novartis Pharmaceuticals 279
Testing effectiveness (Phase 2)Study completedNCT02513498
What this trial is testing

Ixazomib Citrate in Treating Patients With Chronic Graft-versus-Host Disease

Who this might be right for
Chronic Graft Versus Host Disease
Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT02587234
What this trial is testing

Driving Neuroplasticity With Nerve Stimulation and Modified CIT

Who this might be right for
StrokeCerebrovascular Accident
University of Kentucky 21
Testing effectiveness (Phase 2)Study completedNCT02065154
What this trial is testing

Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndrome+3 more
University of Alabama at Birmingham 39
Testing effectiveness (Phase 2)Study completedNCT02759731
What this trial is testing

Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Chronic Graft vs Host DiseaseChronic Graft-Versus-Host Disease
National Cancer Institute (NCI) 24
Not applicableLooking for participantsNCT06921694
What this trial is testing

A Combined Exercise Programme Involving Strengthening, Flexibility and Aerobic Exercise for Lower Back Pain

Who this might be right for
Low Back Pain, Chronic
University of Nottingham 88
Testing effectiveness (Phase 2)Study completedNCT01390402
What this trial is testing

Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG

Who this might be right for
LeukemiaChronic Myelogenous Leukemia
M.D. Anderson Cancer Center 6
Large-scale testing (Phase 3)Study completedNCT00755040
What this trial is testing

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Vanderbilt-Ingram Cancer Center 164
Not applicableUnknownNCT00587574
What this trial is testing

Prospective Phase II Study for Assessment of Regulatory Immune Cell Populations After Allogeneic HSCT

Who this might be right for
Allogeneic Hematopoietic Cell Transplant Recipients
Medical University of Vienna 150
Next Page